Relpax
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Which Triptan?— Opportunity for Same or Better Outcomes at Lower Cost With 7 triptans on the market in the United States, there…
1. In comparing the effectiveness and duration of response of different triptans in reducing the severity and duration of…
The development of a second-generation process for the synthesis of eletriptan via a Fischer indole cyclisation is described. The…
Eletriptan (Relpax) is an orally administered, lipophilic, highly selective serotonin 5-HT(1B/1D) receptor agonist ('triptan…
Eletriptan (Relpax®)2 is an orally administered, lipophilic, highly selective serotonin 5-HT1B/1D receptor agonist (‘triptan…
Eletriptan (Relpax) is a new anti-migraine medication commonly referred to as triptans. Eletriptan is considered to reduce…
Eletriptan (Relpax) is a novel 5-hydroxytryptamine (serotonin)(1D/1B) agonist currently in development for the acute treatment of…